Sounds good. Because of znga's screw-up we can buy a company for 16 which should be at 20 - 40 range. Hopefully they continue to deliver
but I was tempted at 5, 4, 3, 2.50... I guess the ipo was just a chance to cash out on Farmville, it's not really a company it's just the Farmville cash out stock
it's rare to close at the high, no matter how strong a stock is. which is why the S&P threw me for a loop today, going into a 3 day weekend, too!
I only saw one, if it's the same one you saw that is an automated report based on canned algorithms. Don't worry, nobody of consequence is going to base their investment decisions on that! lol
Looked it up. Interesting. I get the feeling that these competing companies sort of hate each other. He also mentioned that they will have cured most of the patient population in a few years. That may be part of the problem for achn, since they are very far from market.
Well, if you're a nimble trader they can make you money. But a lot of retail investors are not. The pump eventually ends, and the last guys to buy get screwed. I'm not as negative towards them as my post sounds, but it sums up my overall opinion. Seeking alpha is probably worse, but I just don't like the blatant manipulation. They use very aggressive marketing to promote stocks. On the other hand I eventually gave in and bought swir. If it's going up, might as well join the party and make some money.
Haha I check the price action on my watch list but nothing major happened so I didn't see they reported 5 days ago! The comments are very encouraging. It's frustrating to have no idea how it will translate to revenue. If big pharmas are really that interested this might be the winner of a lifetime
It will fall by twice the value of div after ex date. One time divs usually do. But it could run up a lot going in. This is no znga, they are grossly undervalue
You sure do have the optimistic angle covered! I hope you're right, triple digits would be more than welcome
It's definitely oversold, where it goes from here I have no idea